Advanced search
Publication Cover
Clinical Toxicology Volume 61, 2023 - Issue 12
Submit an article Journal homepage
469
Views
1
CrossRef citations to date
0
Altmetric
Clinical Research

Qualitative and quantitative characteristics of xylazine-associated deaths detected using a post-mortem toxicology testing program

Varun Vohraa Department of Emergency Medicine, Michigan Poison & Drug Information Center, Wayne State University School of Medicine, Detroit, MI, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-9471-2348View further author information
ORCID Icon,
Gabrielle K. Stroh-Steinerb Michigan Department of Health and Human Services, Lansing, MI, USAView further author information
&
Prentiss Jonesc Pathology, Western Michigan University Homer Stryker M.D. School of Medicine, Kalamazoo, MI, USAView further author information
Pages 1040-1046 | Received 14 Sep 2023, Accepted 22 Nov 2023, Published online: 13 Dec 2023

References

  • Spencer MR, Minino AM, Warner M. Drug overdose deaths in the United States, 2001–2021. Hyattsville (MD): National Center for Health Statistics (US); 2022.
  • Kariisa M, Scholl L, Wilson N, et al. Drug overdose deaths involving cocaine and psychostimulants with abuse potential—United States, 2003–2017. MMWR Morb Mortal Wkly Rep. 2019;68(17):388–395. doi: 10.15585/mmwr.mm6817a3.
  • Hassan AN, Le Foll B. Polydrug use disorders in individuals with opioid use disorder. Drug Alcohol Depend. 2019;198:28–33. doi: 10.1016/j.drugalcdep.2019.01.031.
  • Park JN, Schneider KE, Fowler D, et al. Polysubstance overdose deaths in the fentanyl era: a latent class analysis. J Addict Med. 2022;16(1):49–55. doi: 10.1097/ADM.0000000000000823.
  • Golladay M, Donner K, Nechuta S. Using statewide death certificate data to understand trends and characteristics of polydrug overdose deaths in Tennessee, 2013–2017. Ann Epidemiol. 2020;41:43–48.e1. doi: 10.1016/j.annepidem.2019.12.001.
  • Rhee TG, Ross JS, Rosenheck RA, et al. Accidental drug overdose deaths in Connecticut, 2012–2018: the rise of polysubstance detection? Drug Alcohol Depend. 2019;205:107671. doi: 10.1016/j.drugalcdep.2019.107671.
  • Gupta R, Holtgrave DR, Ashburn MA. Xylazine—medical and public health imperatives. N Engl J Med. 2023;388(24):2209–2212. doi: 10.1056/NEJMp2303120.
  • The Growing Threat of xylazine and its mixture with illicit drugs. Springfield (VA): US Drug Enforcement Administration; 2022. Available from: https://www.dea.gov/sites/default/files/2022-12/The%20Growing%20Threat%20of%20Xylazine%20and%20its%20Mixture%20with%20Illicit%20Drugs.pdf
  • Kariisa M, O’Donnell J, Kumar S, et al. Illicitly manufactured fentanyl–involved overdose deaths with detected xylazine—United States, January 2019–June 2022. MMWR Morb Mortal Wkly Rep. 2023;72(26):721–727. doi: 10.15585/mmwr.mm7226a4.
  • Kariisa M, Patel P, Smith H, et al. Notes from the field: xylazine detection and involvement in drug overdose deaths—United States, 2019. MMWR Morb Mortal Wkly Rep. 2021;70(37):1300–1302. doi: 10.15585/mmwr.mm7037a4.
  • Friedman J, Montero F, Bourgois P, et al. Xylazine spreads across the US: a growing component of the increasingly synthetic and polysubstance overdose crisis. Drug Alcohol Depend. 2022;233:109380. doi: 10.1016/j.drugalcdep.2022.109380.
  • Michigan Department of Health and Human Services. Michigan overdose data to action dashboard: specific drug trends. 2023 [cited 2023 Sep 6]. Available from: https://www.michigan.gov/opioids/category-data
  • D’Orazio J, Nelson L, Perrone J, et al. Xylazine adulteration of the Heroin-Fentanyl drug supply: a narrative review. Ann Intern Med. 2023;176(10):1370–1376. doi: 10.7326/M23-2001.
  • Kacinko SL, Mohr ALA, Logan BK, et al. Xylazine: pharmacology review and prevalence and drug combinations in forensic toxicology casework. J Anal Toxicol. 2022;46(8):911–917. doi: 10.1093/jat/bkac049.
  • Ball NS, Knable BM, Relich TA, et al. Xylazine poisoning: a systematic review. Clin Toxicol. 2022;60(8):892–901. doi: 10.1080/15563650.2022.2063135.
  • Briellmann TA, Rickli R, Jenny C. A fatal intoxication with xylazine. Basel, Switzerland: Laboratory of Forensic Chemistry; 1994. p. 28–30. Report No.: 1.
  • Ayub S, Parnia S, Poddar K, et al. Xylazine in the opioid epidemic: a systematic review of case reports and clinical implications. Cureus. 2023;15(3):e36864. doi: 10.7759/cureus.36864.
  • Love JS, Levine M, Aldy K, et al. Opioid overdoses involving xylazine in emergency department patients: a multicenter study. Clin Toxicol (Phila). 2023;61(3):173–180. doi: 10.1080/15563650.2022.2159427.
  • Logan BK, Kacinko SL, Menendez MJ, et al. Appropriate consideration and interpretation of xylazine in deaths involving fentanyl [abstract]. National Association of Medical Examiners (NAME) Annual Meeting; October 13–17, 2023; San Jose, CA.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.